Granzyme H Serum Levels Variations with Both Reproductive Hormone Receptors, and Related Hormone Receptors in Breast Cancer Patients

Author(s):
Behnoosh Tahbaz-lahafBehnoosh Tahbaz-lahaf1, MohammadEsmaeil AkbariMohammadEsmaeil Akbari2,*, Houshang Amir-RassouliHoushang Amir-Rassouli1, Ali RahimipourAli Rahimipour1, Eznollah AzargashbEznollah Azargashb2, Nahid NafissiNahid Nafissi2, Farida JahaniFarida Jahani2
1Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
*Corresponding Author: Corresponding author: MohammadEsmaeil Akbari, Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Tel: +98-2122748001, E-mail: Email: [email protected]

International Journal of Cancer Management:Vol. 7, issue 1; e80509
Published online:Mar 31, 2014
Article type:Research Article
Received:Nov 02, 2013
Accepted:Dec 21, 2013
How to Cite:Tahbaz-lahaf B, Akbari M, Amir-Rassouli H, Rahimipour A, Azargashb E, et al. Granzyme H Serum Levels Variations with Both Reproductive Hormone Receptors, and Related Hormone Receptors in Breast Cancer Patients. Int J Cancer Manag. 2014;7(1):e80509. doi:

Abstract

Background: Breast Cancer (BC) is the most common cancer in Iranian women, meanwhile the Iranian patients are relatively young. Granzyme H (GZMH) is a functional cytotoxic serine protease of NK cell granules, which expands the cell death-inducing repertoire of innate immune system. GZMH is constitutively and highly expressed in human NK cells, in order to possess chymotrypsin-like (chymase) enzymatic activity. The purpose of this study was to determine GZMH level, in BC and healthy women.

Methods: 30 breast cancer patients, and 30 control women in premenopausal status, have participated in this study. GZMH, Estrogen levels, and ER, PR have been measured in cancer and healthy women subsequently, as using ELISA, Radioimmunoassay, and Immunohistochemistry methods.

Results: Mean GZMH value was lower in BC than healthy women (p<0.0001).

Conclusion: Our study has implicated existence of suppressor or problem for producing of GZMH in patients group and levels of estrogen couldn’t effect on making positive ER, PR.

Fulltext

Full text is available in PDF.

Copyright

© 2014, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

20
Jun
2007

Granzyme B Level in Acute Renal Transplant Rejection

N Zarghami,
S Samadzadeh,
H Fani,
B Alani

Zarghami N, Samadzadeh S, Fani H, Alani B. Granzyme B Level in Acute Renal Transplant Rejection. J Kermanshah Univ Med Sci. 2007;11(1):e81861. doi:

28
Feb
2018

The Differences of Age, Tumor Grade, and Her2 Amplification in Estrogen and Progesterone Receptor Status in Patients with Breast Cancer

Elnaz Sheikhpour,
Shokouh Taghipour

Sheikhpour E, Taghipour S. The Differences of Age, Tumor Grade, and Her2 Amplification in Estrogen and Progesterone Receptor Status in Patients with Breast Cancer. Int J Cancer Manag. 2018;11(8):e9492. doi: https://doi.org/10.5812/ijcm.9492

6
Jun
2020
International Journal of Cancer Management

Comparison of ER, PR, Ki67 and HER-2/neu Reactivity Pattern with Patients’ Age, Histologic Grade, Tumor Size and Lymph Node Status in Invasive Ductal Breast Cancer

Mahsa Ahadi,
Motahareh Heibatollahi,
Sara Zahedifard

Ahadi M, Heibatollahi M, Zahedifard S. Comparison of ER, PR, Ki67 and HER-2/neu Reactivity Pattern with Patients’ Age, Histologic Grade, Tumor Size and Lymph Node Status in Invasive Ductal Breast Cancer. Int J Cancer Manag. 2020;13(6):e98325. doi: https://doi.org/10.5812/ijcm.98325

31
Mar
2014

The Stromal Overexpression of CD10 in Invasive Breast Cancer and its Association with Clincophathologic Factors

Ali Taghizadeh-Kermani,
Amir Hossein Jafarian,
Reza Ashabyamin,
Mehdi Seilanian-Toosi,
Leila Pourali,
Mehdi Asadi
,et al.

Taghizadeh-Kermani A, Jafarian AH, Ashabyamin R, Seilanian-Toosi M, Pourali L, et al. The Stromal Overexpression of CD10 in Invasive Breast Cancer and its Association with Clincophathologic Factors. Int J Cancer Manag. 2014;7(1):e80503. doi:

5
Apr
2020
International Journal of Cancer Management

Clinicopathologic Features and Prognostic Role of CD3, CD8, and PD-1 positive Tumor-Infiltrating Lymphocytes and the Association with COX-2 Overexpression in Endometrial Carcinoma

Niusha Nobari,
Nakisa Niknejad,
Jalal Poorolajal,
Maryam Vaezi,
Fatemeh Nili,
Issa Jahanzad

Nobari N, Niknejad N, Poorolajal J, Vaezi M, Nili F, et al. Clinicopathologic Features and Prognostic Role of CD3, CD8, and PD-1 positive Tumor-Infiltrating Lymphocytes and the Association with COX-2 Overexpression in Endometrial Carcinoma. Int J Cancer Manag. 2020;13(4):e99210. doi: https://doi.org/10.5812/ijcm.99210

Download PDF116.19 KB
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles